Versant Venture Management »

Century Therapeutics shares owned by Versant Venture Management

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by Versant Venture Management from 13F filings

Historical chart of Versant Venture Management investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by Versant Venture Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $28M 12M 2.26

More positions owned by Versant Venture Management

Monte Rosa Therapeutics Common Stock (GLUE)
Century Therapeutics Common Stock (IPSC)
Lenz Therapeutics Common Stock (LENZ)
Jade Biosciences Common Stock (JBIO)
Contineum Therapeutics Common Stock (CTNM)
CRISPR Therapeutics Common Shares (CRSP)
Skye Bioscience Common Stock (SKYE)
Tempest Therapeutics Common Stock

View all positions for Versant Venture Management

Top funds holding Century Therapeutics

Versant Venture Management
Point72 Asset Management
Vanguard Capital Management
DAFNA Capital Management
Vanguard Group
Adage Capital Partners GP
Two Sigma Investments
Renaissance Technologies
Two Sigma Advisers
Casdin Capital
Acadian Asset Management
Syncona Portfolio
Vanguard Fiduciary Trust
Millennium Management
BlackRock

View all funds holding Century Therapeutics